These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1757335)

  • 21. Acute effects of exercise on MR imaging of skeletal muscle in normal volunteers.
    Fleckenstein JL; Canby RC; Parkey RW; Peshock RM
    AJR Am J Roentgenol; 1988 Aug; 151(2):231-7. PubMed ID: 3260716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotype consequences of myophosphorylase dysfunction: insights from the McArdle mouse model.
    Brull A; de Luna N; Blanco-Grau A; Lucia A; Martin MA; Arenas J; Martí R; Andreu AL; Pinós T
    J Physiol; 2015 Jun; 593(12):2693-706. PubMed ID: 25873271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Excess purine degradation in exercising muscles of patients with glycogen storage disease types V and VII.
    Mineo I; Kono N; Shimizu T; Hara N; Yamada Y; Sumi S; Nonaka K; Tarui S
    J Clin Invest; 1985 Aug; 76(2):556-60. PubMed ID: 3861621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose infusion abolishes the excessive ATP degradation in working muscles of a patient with McArdle's disease.
    Mineo I; Kono N; Yamada Y; Hara N; Kiyokawa H; Hamaguchi T; Kawachi M; Yamasaki T; Nakajima H; Kuwajima M
    Muscle Nerve; 1990 Jul; 13(7):618-20. PubMed ID: 2388661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxygen consumption is increased relative to work rate in patients with McArdle's disease.
    O'Dochartaigh CS; Ong HY; Lovell SM; Riley MS; Patterson VH; Young IS; Nicholls DP
    Eur J Clin Invest; 2004 Nov; 34(11):731-7. PubMed ID: 15530145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of lipid peroxidation in McArdle's disease: applications for treatment of other myopathies.
    Russo PJ; Phillips JW; Seidler NW
    Med Hypotheses; 1992 Oct; 39(2):147-51. PubMed ID: 1461177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 13C-NMR measurements of muscle glycogen during low-intensity exercise.
    Price TB; Rothman DL; Avison MJ; Buonamico P; Shulman RG
    J Appl Physiol (1985); 1991 Apr; 70(4):1836-44. PubMed ID: 2055862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased insulin action in skeletal muscle from patients with McArdle's disease.
    Nielsen JN; Vissing J; Wojtaszewski JF; Haller RG; Begum N; Richter EA
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1267-75. PubMed ID: 12006356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance limits glucose utilization and exercise tolerance in myophosphorylase deficiency and NIDDM.
    Dorin RI; Field JC; Boyle PJ; Eaton RP; Icenogle MV
    J Appl Physiol (1985); 1996 Sep; 81(3):1273-8. PubMed ID: 8889763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breakdown of adenine nucleotide pool in fatiguing skeletal muscle in McArdle's disease: a noninvasive 31P-MRS and EMG study.
    Zange J; Grehl T; Disselhorst-Klug C; Rau G; Müller K; Schröder R; Tegenthoff M; Malin JP; Vorgerd M
    Muscle Nerve; 2003 Jun; 27(6):728-36. PubMed ID: 12766985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of oral sucrose on exercise tolerance in patients with McArdle's disease.
    Vissing J; Haller RG
    N Engl J Med; 2003 Dec; 349(26):2503-9. PubMed ID: 14695410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [McArdle's disease. Apropos of a case].
    Yuste JR; Beloqui O; De la Peña A; Rodríguez-Rosado R; Monreal JI; Prósper F; Prieto J
    Rev Med Univ Navarra; 1998; 42(1):29-33. PubMed ID: 10420954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscle fatigue in McArdle's disease studied by 31P-NMR: effect of glucose infusion.
    Lewis SF; Haller RG; Cook JD; Nunnally RL
    J Appl Physiol (1985); 1985 Dec; 59(6):1991-4. PubMed ID: 3865926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lactate and Energy Metabolism During Exercise in Patients With Blocked Glycogenolysis (McArdle Disease).
    Ørngreen MC; Jeppesen TD; Taivassalo T; Hauerslev S; Preisler N; Heinicke K; Haller RG; Vissing J; van Hall G
    J Clin Endocrinol Metab; 2015 Aug; 100(8):E1096-104. PubMed ID: 26030324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muscle proton T2 relaxation times and work during repetitive maximal voluntary exercise.
    Fleckenstein JL; Watumull D; McIntire DD; Bertocci LA; Chason DP; Peshock RM
    J Appl Physiol (1985); 1993 Jun; 74(6):2855-9. PubMed ID: 8396107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exercise-induced muscle modifications: study of healthy subjects and patients with metabolic myopathies with MR imaging and P-31 spectroscopy.
    de Kerviler E; Leroy-Willig A; Jehenson P; Duboc D; Eymard B; Syrota A
    Radiology; 1991 Oct; 181(1):259-64. PubMed ID: 1887044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [MR-Imaging of lower leg muscle perfusion].
    Leppek R; Hoos O; Sattler A; Kohle S; Azzam S; Al Haffar I; Keil B; Ricken P; Klose KJ; Alfke H
    Herz; 2004 Feb; 29(1):32-46. PubMed ID: 14968340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance exercise-induced fluid shifts: change in active muscle size and plasma volume.
    Ploutz-Snyder LL; Convertino VA; Dudley GA
    Am J Physiol; 1995 Sep; 269(3 Pt 2):R536-43. PubMed ID: 7573553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased PFK activity and GLUT4 protein content in McArdle's disease.
    Robertshaw HA; Raha S; Kaczor JJ; Tarnopolsky MA
    Muscle Nerve; 2008 Apr; 37(4):431-7. PubMed ID: 18067156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exercise intolerance in patients with McArdle's disease or mitochondrial myopathies.
    Chaussain M; Camus F; Defoligny C; Eymard B; Fardeau M
    Eur J Med; 1992 Dec; 1(8):457-63. PubMed ID: 1341204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.